A Smart + Strong Site
Subscribe to:
• E-newsletters
• POZ magazine
POZ Personals
Sign In / Join		 Username:
 Password:
Back to home » Top Stories » CROI 2010
17th Conference on Retroviruses and Opportunistic Infections
CROI 2010 17th Conference on Retroviruses and Opportunistic Infections
Moscone Center West
San Francisco, CA
February 16-19, 2010

New Treatments for HIV: Part 1

March 9, 2010

By Tim Horn

At the 17th Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco—Tim Horn speaks with David Hardy, MD, from Cedars Sinai Medical Center in Los Angeles, about new HIV treatments—including the drug blood level-booster, cobicistat, and the new integrase inhibitor, elvitegravir. Part 1 of a 2-part video.

 


7 minutes. Transcript Coming Soon.

Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       

More from CROI 2010

HIV/AIDS Complications

March 9, 2010
HIV and the Brain: Part 2
March 8, 2010
Cancer Risks and HIV
HIV and the Brain: Part 1
March 1, 2010
HIV and Bone Health
February 25, 2010
Bone Fracture Risk Higher Among People Living With HIV
Vitamin D Deficiency Common Among HIV Positive
February 24, 2010
HIV in the Brain Usually Matches Levels in the Blood
Hep C Treatment Might Also Guard Against HIV Disease Progression
February 23, 2010
Truvada and Norvir-Boosted Reyataz More Likely to Cause Bone Loss in ACTG Study
Maintaining Higher CD4s Protects Against Brain Damage
February 20, 2010
HIV and Heart Disease Risks
February 19, 2010
Increased Risk of Chronic Kidney Disease Linked to Tenofovir and Atazanavir
Non-AIDS Cancer Risk Decreases With Higher CD4 Cell Counts
Smoking Cessation Reduces Cardiovascular Disease Risk in HIV
February 18, 2010
H1N1 Meets HIV
HIV Contributes to Lung Cancer Risk, but Not Nearly as Much as Smoking

HIV Transmission and Prevention

March 8, 2010
HIV Prevention: On the Verge of Success?
HIV Treatment in Southern Africa
March 1, 2010
One in Six New HIV Cases Involves Drug-Resistant Virus
February 22, 2010
Routine HIV Testing Proving Successful in Washington, DC
Testing and Treatment Tied to Fewer New HIV Cases in S.F. & Vancouver Studies

Starting and Switching Treatment

March 2, 2010
Normal Life Expectancy With Maintenance of CD4s Above 500
February 22, 2010
Testing and Treatment Tied to Fewer New HIV Cases in S.F. & Vancouver Studies
February 19, 2010
No Efficacy Differences in ACTG Study Comparing Sustiva or Reyataz with either Epzicom or Truvada
February 18, 2010
Once-Daily Prezista Effective, Safer for HIV Treatment-Experienced Patients

Experimental HIV Drugs

March 9, 2010
New Treatments for HIV: Part 1
New Treatments for HIV: Part 2
February 18, 2010
New CCR5 Antagonist Shows Promise in Early Study
Vicriviroc Falls Short in Treatment-Experienced HIV Studies
February 17, 2010
Quad Pill and Boosting Drug Show Well in Studies


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.